Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 1
2000 6
2001 1
2002 11
2003 5
2004 4
2005 7
2006 11
2007 8
2008 7
2009 5
2010 5
2011 2
2012 2
2013 5
2014 3
2015 4
2016 10
2017 3
2018 4
2019 9
2020 9
2021 5
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Results by year
Filters applied: . Clear all
Page 1
Neurostimulation for Parkinson's disease with early motor complications.
Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Hälbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltête D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Krüger R, Pinsker MO, Amtage F, Régis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G; EARLYSTIM Study Group. Schuepbach WM, et al. Among authors: houeto jl. N Engl J Med. 2013 Feb 14;368(7):610-22. doi: 10.1056/NEJMoa1205158. N Engl J Med. 2013. PMID: 23406026 Free article. Clinical Trial.
Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig TD, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, Kühn A, Kupsch A, Schneider GH, Seigneuret E, Fraix V, Kistner A, Chaynes PP, Ory-Magne F, Brefel-Courbon C, Vesper J, Wojtecki L, Derrey S, Maltête D, Damier P, Derkinderen P, Sixel-Döring F, Trenkwalder C, Gharabaghi A, Wächter T, Weiss D, Pinsker MO, Regis JM, Witjas T, Thobois S, Mertens P, Knudsen K, Schade-Brittinger C, Houeto JL, Agid Y, Vidailhet M, Timmermann L, Deuschl G; EARLYSTIM study group. Schuepbach WMM, et al. Among authors: houeto jl. Neurology. 2019 Mar 5;92(10):e1109-e1120. doi: 10.1212/WNL.0000000000007037. Epub 2019 Feb 8. Neurology. 2019. PMID: 30737338 Free PMC article. Clinical Trial.
Myths and facts about the EARLYSTIM study.
Schüpbach WM, Rau J, Houeto JL, Krack P, Schnitzler A, Schade-Brittinger C, Timmermann L, Deuschl G. Schüpbach WM, et al. Among authors: houeto jl. Mov Disord. 2014 Dec;29(14):1742-50. doi: 10.1002/mds.26080. Epub 2014 Nov 14. Mov Disord. 2014. PMID: 25399678 Review.
Tactile Temporal Discrimination Is Impaired in Myoclonus-Dystonia.
Tarrano C, Lamy JC, Delorme C, McGovern EM, Atkinson-Clement C, Brochard V, Thobois S, Tranchant C, Grabli D, Degos B, Corvol JC, Pedespan JM, Krystkoviak P, Houeto JL, Degardin A, Defebvre L, Apartis E, Vidailhet M, Roze E, Worbe Y. Tarrano C, et al. Among authors: houeto jl. Mov Disord. 2020 Dec;35(12):2356-2357. doi: 10.1002/mds.28253. Epub 2020 Sep 22. Mov Disord. 2020. PMID: 32960985 No abstract available.
Pathophysiology of Parkinson's disease.
Bonnet AM, Houeto JL. Bonnet AM, et al. Among authors: houeto jl. Biomed Pharmacother. 1999 Apr;53(3):117-21. doi: 10.1016/S0753-3322(99)80076-6. Biomed Pharmacother. 1999. PMID: 10349507 Review.
Visual sensory processing is altered in myoclonus dystonia.
Tarrano C, Wattiez N, Delorme C, McGovern EM, Brochard V, Thobois S, Tranchant C, Grabli D, Degos B, Corvol JC, Pedespan JM, Krystkoviak P, Houeto JL, Degardin A, Defebvre L, Valabrègue R, Vidailhet M, Pouget P, Roze E, Worbe Y. Tarrano C, et al. Among authors: houeto jl. Mov Disord. 2020 Jan;35(1):151-160. doi: 10.1002/mds.27857. Epub 2019 Sep 30. Mov Disord. 2020. PMID: 31571302
Deep brain stimulation: preoperative issues.
Lang AE, Houeto JL, Krack P, Kubu C, Lyons KE, Moro E, Ondo W, Pahwa R, Poewe W, Tröster AI, Uitti R, Voon V. Lang AE, et al. Among authors: houeto jl. Mov Disord. 2006 Jun;21 Suppl 14:S171-96. doi: 10.1002/mds.20955. Mov Disord. 2006. PMID: 16810718
Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial.
Rascol O, Cochen de Cock V, Pavy-Le Traon A, Foubert-Samier A, Thalamas C, Sommet A, Rousseau V, Perez-Lloret S, Fabbri M, Azulay JP, Corvol JC, Couratier P, Damier P, Defebvre L, Durif F, Geny C, Houeto JL, Remy P, Tranchant C, Verin M, Tison F, Meissner WG; MSA-FLUO Study Group. Rascol O, et al. Among authors: houeto jl. Mov Disord. 2021 Jul;36(7):1704-1711. doi: 10.1002/mds.28569. Epub 2021 Apr 1. Mov Disord. 2021. PMID: 33792958 Clinical Trial.
Parkinson's disease is a neuropsychiatric disorder.
Agid Y, Arnulf I, Bejjani P, Bloch F, Bonnet AM, Damier P, Dubois B, François C, Houeto JL, Iacono D, Karachi C, Mesnage V, Messouak O, Vidailhet M, Welter ML, Yelnik J. Agid Y, et al. Among authors: houeto jl. Adv Neurol. 2003;91:365-70. Adv Neurol. 2003. PMID: 12442695 Review. No abstract available.
121 results